DOPRAM-V (DOXAPRAM HYDROCHLORIDE INJECTION) DIN 01914154
Status: Cancelled Post Market
Holder: WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA
Molecule: DOXAPRAM HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | DOXAPRAM HYDROCHLORIDE 20 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous; Sublingual |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1991 |
| Current status date | 26-Aug-2004 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOXAPRAM HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01914103 | DOPRAM INJ 20MG/ML | AYERST LABORATORIES | Liquid | DOXAPRAM HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02041839 | DOPRAM INJECTABLE LIQ 20MG/ML | WYETH-AYERST CANADA INC. | Liquid | DOXAPRAM HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02319454 | RESPIRAM | MODERN VETERINARY THERAPEUTICS LLC | Solution | DOXAPRAM HYDROCHLORIDE 20 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3354 | 2003-11-14 | New Drug Submission (NDS) |
International API supply for DOXAPRAM HYDROCHLORIDE
2 active FDA Drug Master Files.
Request a quote for DOPRAM-V (DOXAPRAM HYDROCHLORIDE INJECTION)